Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria
Clinical trial NCT01732471 · COMPLETED
Trial details
- NCT number
- NCT01732471
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.